Prices are checked against each store and labelled with when.
It checks today's price at every store, compares the alternatives and answers in about a minute.
Tirzepatide is a once-weekly injectable that activates both GLP-1 and GIP hormone pathways. That dual action is its main difference from older GLP-1-only drugs such as semaglutide, and head-to-head trials have shown greater average weight loss with tirzepatide. It suits adults with obesity or excess weight who want medication alongside diet and exercise, and it requires a prescription and medical supervision. Common side effects are mostly digestive, especially nausea and constipation, and they tend to ease as the dose is stepped up.
In stock
Users of tirzepatide generally report strong appetite suppression and steady weight loss, with many calling it more effective than semaglutide. Most complaints center on digestive side effects during dose increases.
Tirzepatide is a once-weekly injectable medication intended to support weight loss, energy and metabolic balance. It activates two natural hormone pathways, GLP-1 and GIP. Together these hormones help regulate appetite, blood sugar, insulin response, feeling full and fat metabolism.
It helps the body feel full sooner and stay full longer. It also reduces food cravings, stabilizes blood sugar and improves insulin sensitivity.
It is used to support weight loss, increased energy, reduced inflammation and better metabolic health.
